{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:25:49Z","timestamp":1771464349927,"version":"3.50.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,1]]},"DOI":"10.1093\/humrep\/dei210","type":"journal-article","created":{"date-parts":[[2005,7,22]],"date-time":"2005-07-22T00:24:13Z","timestamp":1121991853000},"page":"3192-3197","source":"Crossref","is-referenced-by-count":43,"title":["Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment"],"prefix":"10.1093","volume":"20","author":[{"given":"I.E.","family":"Messinis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Loutradis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Domali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.P.","family":"Kotsovassilis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Papastergiopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kallitsaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Drakakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Dafopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Milingos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,7,21]]},"reference":[{"key":"key\n\t\t\t\t20171012102959_ALBANO-ET-AL-2000","doi-asserted-by":"crossref","unstructured":"Albano C , Felberbaum RE, Smitz J, Riethmuller-Winzen H, Engel J, Diedrich K and Devroey P (2000) Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod15,526\u2013531.","DOI":"10.1093\/humrep\/15.3.526"},{"key":"key\n\t\t\t\t20171012102959_AL-INANY-AND-ABOULGHAR-2002","doi-asserted-by":"crossref","unstructured":"Al-Inany H and Aboulghar M (2002) GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 17,874\u2013885.","DOI":"10.1093\/humrep\/17.4.874"},{"key":"key\n\t\t\t\t20171012102959_BORM-AND-MANNAERTS-2000","doi-asserted-by":"crossref","unstructured":"Borm G and Mannaerts B (2000) Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod15,1490\u20131498.","DOI":"10.1093\/humrep\/15.7.1490"},{"key":"key\n\t\t\t\t20171012102959_DIEDRICH-ET-AL-1994","doi-asserted-by":"crossref","unstructured":"Diedrich K , Diedrich C, Santos E, Zoll C, al-Hasani S, Reissmann T, Krebs D and Klingmuller D (1994) Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 9,788\u2013791.","DOI":"10.1093\/oxfordjournals.humrep.a138597"},{"key":"key\n\t\t\t\t20171012102959_DIEDRICH-ET-AL-2002","unstructured":"Diedrich K , Ludwig M and Felberbaum R (2002) GnRH antagonists. In Tarlatzis B (ed) Ovulation induction. Elsevier, Paris, France, pp 171\u2013184."},{"key":"key\n\t\t\t\t20171012102959_DUBOURDIEU-ET-AL-1994","unstructured":"Dubourdieu S , Charbonnel B, d\u2019Acremont MF, Carreau S, Spitz IM and Bouchard P (1994) Effect of administration of a GnRH antagonist (Nal-Glu) during the periovulatory period: the LH surge requires secretion of gonadotropin-releasing hormone. J Clin Endocrinol Metab78,343\u2013347."},{"key":"key\n\t\t\t\t20171012102959_EUROPEAN-2001","doi-asserted-by":"crossref","unstructured":"European and Middle East Orgalutran Study Group (2001) Comparable clinical outcome using the GnRH antagonist ganirelix of a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod16,644\u2013651","DOI":"10.1093\/humrep\/16.4.644"},{"key":"key\n\t\t\t\t20171012102959_FELBERBAUM-ET-AL-2000","doi-asserted-by":"crossref","unstructured":"Felberbaum RE , Albano C, Ludwig M, Riethmuller-Winzen H, Grigat M, Devroey P and Diedrich K (2000) Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist Cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study. Hum Reprod 15,1015\u20131020.","DOI":"10.1093\/humrep\/15.5.1015"},{"key":"key\n\t\t\t\t20171012102959_FLUKER-ET-AL-1991","doi-asserted-by":"crossref","unstructured":"Fluker MR , Marshall LA, Monroe SE and Jaffe RB (1991) Variable ovarian response to gonadotropin-releasing hormone antagonist induced gonadotropin deprivation during different phases of the menstrual cycle. J Clin Endocrinol Metab72,912\u2013919.","DOI":"10.1210\/jcem-72-4-912"},{"key":"key\n\t\t\t\t20171012102959_FLUKER-ET-AL-2001","doi-asserted-by":"crossref","unstructured":"Fluker M , Grifo J, Leader A, Levy M, Meldrum D, Muasher SJ, Rinehart J, Rosenwaks Z, Scott RT Jr, Schoolcraft W and Shapiro DB; North American Ganirelix Study Group (2001) Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril75,38\u201345.","DOI":"10.1016\/S0015-0282(00)01638-1"},{"key":"key\n\t\t\t\t20171012102959_FRYDMAN-ET-AL-1991","doi-asserted-by":"crossref","unstructured":"Frydman R , Cornel C, de Ziegler D, Taieb J, Spitz IM and Bouchard P (1991) Prevention of premature luteinizing hormone and progesterone rise with a gonadotropin-releasing hormone antagonist, Nal-Glu, in controlled ovarian hyperstimulation. Fertil Steril56,923\u2013927.","DOI":"10.1016\/S0015-0282(16)54666-4"},{"key":"key\n\t\t\t\t20171012102959_GANIRELIX-1998","doi-asserted-by":"crossref","unstructured":"Ganirelix Dose-finding Study Group (1998) A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). Hum Reprod13,3023\u20133031.","DOI":"10.1093\/humrep\/13.11.3023"},{"key":"key\n\t\t\t\t20171012102959_GLASIER-ET-AL-1988","doi-asserted-by":"crossref","unstructured":"Glasier A , Thatcher SS, Wickings EJ, Hillier SG and Baird DT (1988) Superovulation with exogenous gonadotropins does not inhibit the luteinizing hormone surge. Fertil Steril49,81\u201385.","DOI":"10.1016\/S0015-0282(16)59653-8"},{"key":"key\n\t\t\t\t20171012102959_HERNANDEZ-2000","doi-asserted-by":"crossref","unstructured":"Hernandez ER (2000) Embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod15,1211\u20131216.","DOI":"10.1093\/humrep\/15.6.1211"},{"key":"key\n\t\t\t\t20171012102959_JANSSENS-ET-AL-2000","doi-asserted-by":"crossref","unstructured":"Janssens RM , Lambalk CB, Vermeiden JP, Schats R, Bernards JM, Rekers-Mombarg LT and Schoemaker J (2000) Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study. Hum Reprod15, 2333\u20132340.","DOI":"10.1093\/humrep\/15.11.2333"},{"key":"key\n\t\t\t\t20171012102959_KENIGSBERG-ET-AL-1984","doi-asserted-by":"crossref","unstructured":"Kenigsberg D , Littman BA and Hodgen GB (1984) Medical hypophysectomy: I. Dose\u2013response using a gonadotropin-releasing hormone antagonist. Fertil Steril42,112\u2013115","DOI":"10.1016\/S0015-0282(16)47968-9"},{"key":"key\n\t\t\t\t20171012102959_KOL-ET-AL-1999","doi-asserted-by":"crossref","unstructured":"Kol S , Lightman A, Hilljensjo T, Devroey P, Fauser B, Tarlatzis B, Mannaerts B and Itskovitz-Eldor J (1999) High doses of GnRH antagonists in IVF cycles do not adversely affect the outcome of subsequent freeze\u2013thaw cycles. Hum Reprod14,2242\u20132244.","DOI":"10.1093\/humrep\/14.9.2242"},{"key":"key\n\t\t\t\t20171012102959_KOLIBIANAKIS-ET-AL-2003A","doi-asserted-by":"crossref","unstructured":"Kolibianakis EM , Albano C, Kahn J, Camus M, Tournaye H, Van Steirteghem AC and Devroey P (2003a) Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril79,873\u2013880.","DOI":"10.1016\/S0015-0282(02)04920-8"},{"key":"key\n\t\t\t\t20171012102959_KOLIBIANAKIS-ET-AL-2003B","doi-asserted-by":"crossref","unstructured":"Kolibianakis EM , Bourgain C, Platteau P, Albano C, Van Steirteghem AC and Devroey P (2003b) Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotrophin-releasing hormone antagonists. Fertil Steril80,464\u2013466.","DOI":"10.1016\/S0015-0282(03)00663-0"},{"key":"key\n\t\t\t\t20171012102959_LEROY-ET-AL-1994","doi-asserted-by":"crossref","unstructured":"Leroy I , d\u2019Acremont MF, Brailly-Tabard S, Frydman R, de Mouzon J and Bouchard P (1994) A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge. Fertil Steril62,461\u2013467.","DOI":"10.1016\/S0015-0282(16)56932-5"},{"key":"key\n\t\t\t\t20171012102959_LOUTRADIS-ET-AL-2004","doi-asserted-by":"crossref","unstructured":"Loutradis D , Stefanidis K, Drakakis P, Milingos S, Antsaklis A and Michalas S (2004) A modified gonadotropin-releasing hormone (GnRH) antagonist protocol failed to increase clinical pregnancy rates in comparison with the long GnRH protocol. Fertil Steril 82,1446\u20131448.","DOI":"10.1016\/j.fertnstert.2004.04.051"},{"key":"key\n\t\t\t\t20171012102959_MESSINIS-AND-TEMPLETON-1986","doi-asserted-by":"crossref","unstructured":"Messinis IE and Templeton A (1986) The effect of pulsatile follicle stimulating hormone on the endogenous luteinizing hormone surge in women. Clin Endocrinol25,633\u2013640.","DOI":"10.1111\/j.1365-2265.1986.tb03618.x"},{"key":"key\n\t\t\t\t20171012102959_MESSINIS-AND-TEMPLETON-1987","doi-asserted-by":"crossref","unstructured":"Messinis IE and Templeton AA (1987) Endocrine and follicle characteristics of cycles with and without endogenous luteinizing hormone surges during superovulation induction with pulsatile follicle-stimulating hormone. Hum Reprod2,11\u201316.","DOI":"10.1093\/oxfordjournals.humrep.a136481"},{"key":"key\n\t\t\t\t20171012102959_MESSINIS-AND-TEMPLETON-1989","doi-asserted-by":"crossref","unstructured":"Messinis IE and Templeton AA (1989) Pituitary response to exogenous LHRH in superovulated women. J Reprod Fertil87,633\u2013639.","DOI":"10.1530\/jrf.0.0870633"},{"key":"key\n\t\t\t\t20171012102959_MESSINIS-ET-AL-1985","doi-asserted-by":"crossref","unstructured":"Messinis IE , Templeton, A and Baird DT (1985) Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin. J Clin Endocrinol Metab61,1076\u20131080.","DOI":"10.1210\/jcem-61-6-1076"},{"key":"key\n\t\t\t\t20171012102959_MESSINIS-ET-AL-1998","doi-asserted-by":"crossref","unstructured":"Messinis IE , Milingos S, Zikopoulos K, Hasiotis G, Seferiadis K and Lolis D (1998) Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone. Hum Reprod13,2415\u20132420.","DOI":"10.1093\/humrep\/13.9.2415"},{"key":"key\n\t\t\t\t20171012102959_OLIVENNES-ET-AL-1994","doi-asserted-by":"crossref","unstructured":"Olivennes F , Fanchin R, Bouchard P, de Ziegler D, Taieb J, Selva J and Frydman R (1994) The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization\u2013embryo transfer program. Fertil Steril62,468\u2013476.","DOI":"10.1016\/S0015-0282(16)56933-7"},{"key":"key\n\t\t\t\t20171012102959_OLIVENNES-ET-AL-1998","doi-asserted-by":"crossref","unstructured":"Olivennes F , Alvarez S, Bouchard P, Fanchin R, Salat-Baroux J and Frydman R (1998) The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF\u2013embryo transfer: a dose finding study of 3 versus 2 mg. Hum Reprod13,2411\u20132414.","DOI":"10.1093\/humrep\/13.9.2411"},{"key":"key\n\t\t\t\t20171012102959_TAVANIOTOU-ET-AL-2003","doi-asserted-by":"crossref","unstructured":"Tavaniotou A , Albano C, Van Steirteghem A and Devroey P (2003) The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate\/gonadotrophin\/0.25 mg cetrorelix. Reprod Biomed Online6,421\u2013426.","DOI":"10.1016\/S1472-6483(10)62161-X"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/20\/11\/3192\/9543657\/dei210.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T14:47:39Z","timestamp":1551970059000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/20\/11\/3192\/2913821\/Alternate-day-and-daily-administration-of-GnRH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,21]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2005,7,21]]},"published-print":{"date-parts":[[2005,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dei210","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,11]]},"published":{"date-parts":[[2005,7,21]]}}}